Figure S6 from Macrophage-Derived CXCL9 and CXCL10 Are Required for Antitumor Immune Responses Following Immune Checkpoint Blockade

MLA

Paul A. Beavis, et al. Figure S6 from Macrophage-Derived CXCL9 and CXCL10 Are Required for Antitumor Immune Responses Following Immune Checkpoint Blockade. Mar. 2023. EBSCOhost, https://doi.org/10.1158/1078-0432.22474364.v1.

APA

Paul A. Beavis, Phillip K. Darcy, Sherene Loi, James S. Wilmott, Georgina V. Long, Richard A. Scolyer, Camelia Quek, Tuba N. Gide, Sherly Mardiana, Kevin Sek, Emma V. Petley, Lauren Giuffrida, Melissa A. Henderson, Kirsten L. Todd, Zhi L. Teo, Amanda J. Oliver, Amanda X.Y. Chen, Junyun Lai, Peter Savas, & Imran G. House. (2023). Figure S6 from Macrophage-Derived CXCL9 and CXCL10 Are Required for Antitumor Immune Responses Following Immune Checkpoint Blockade. https://doi.org/10.1158/1078-0432.22474364.v1

Chicago

Paul A. Beavis, Phillip K. Darcy, Sherene Loi, James S. Wilmott, Georgina V. Long, Richard A. Scolyer, Camelia Quek, et al. 2023. “Figure S6 from Macrophage-Derived CXCL9 and CXCL10 Are Required for Antitumor Immune Responses Following Immune Checkpoint Blockade,” March. doi:10.1158/1078-0432.22474364.v1.